You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-40. Treatment Prevalence in 2006: proportion of injectors by primary drug (excluding cannabis) among treated clients in 2006 in nine countries (first treatment incidence, total treatment incidence, total treatment prevalence)

Primary drug	FTI = First Treatment incidence			TTI = Total Treatment incidence			TRP = Total Prevalence
Primary drug	% clients by primary drug	% of injectors	No of injectors by primary drug	% clients by primary drug	% of injectors	No of injectors by primary drug	% clients by primary drug	% of injectors	No of injectors by primary drug
Opioids	37.9	48.2	10312	48	49.6	21189	59.3	63.4	97753
Cocaine	21.2	8.5	1020	18.6	7.8	1285	15.6	5.7	2326
Stimulants (other than cocaine)	7.2	50.4	2052	7.1	61.4	3867	3.8	47.5	4669
Hypnotics and sedatives	2.6	1.8	27	1.2	4.8	51	2.4	3.6	223
Other substances	3.1	5.7	77	1.9	11	113	2.6	37	1285

Notes:

The countries supplying data are: BG, CZ, FR, HU, IT, LV, MT, NL, AU.

FTI: First Treatment Incidence = First Treatments in Life.

TTI: Total Treatment Incidence = First Treatments in Life + Repeated Treatments.

TRP: Total Prevalence = First Treatments in Life + Repeated Treatments + Continuous Treatments.

Other substances include: volatile/inhalants + hallucinogens +other substances.

Cannabis is excluded

Sources:

2007 Reitox national reports - Table TDI by centre type.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)